BIOMAT Database Logo BIOMAT Database Logo

Superparamagnetic particles as oral contrast medium in magnetic resonance imaging of patients with treated ovarian cancer--comparison with plain MRI. 1993

L Prayer, and R Stiglbauer, and J Kramer, and D Wimberger, and D Poelzleitner, and W Schima, and C Kainz, and H Koelbl, and I Haugen, and H Imhof
Department of Radiology, University of Vienna, Austria.

In 23 patients with treated ovarian cancer, 24 magnetic resonance (MR) examinations of the abdomen and pelvis were performed before and after administration of an oral superparamagnetic contrast medium. Depiction of bowel loops was judged sufficient in 47% with plain scans and in 85% with enhanced scans. Minor artefacts attributed to the agent were noted in 32% of examinations and were classified as disturbing in 8%. The diagnostic information obtained after contrast enhancement was estimated to be superior to that from plain MRI in 20% of patients. The use of oral contrast medium did not alter the MR diagnosis of "tumour recurrence" or "disease-free" in any patient. Our results suggest that superparamagnetic iron oxide is an effective and reliable approach to negative bowel contrast enhancement, increasing the confidence level when distinguishing intestines from solid structures.

UI MeSH Term Description Entries
D007501 Iron A metallic element with atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of HEMOGLOBINS; CYTOCHROMES; and IRON-BINDING PROTEINS. It plays a role in cellular redox reactions and in the transport of OXYGEN. Iron-56,Iron 56
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D010087 Oxides Binary compounds of oxygen containing the anion O(2-). The anion combines with metals to form alkaline oxides and non-metals to form acidic oxides. Oxide
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D003287 Contrast Media Substances used to allow enhanced visualization of tissues. Radiopaque Media,Contrast Agent,Contrast Agents,Contrast Material,Contrast Materials,Radiocontrast Agent,Radiocontrast Agents,Radiocontrast Media,Agent, Contrast,Agent, Radiocontrast,Agents, Contrast,Agents, Radiocontrast,Material, Contrast,Materials, Contrast,Media, Contrast,Media, Radiocontrast,Media, Radiopaque
D003911 Dextrans A group of glucose polymers made by certain bacteria. Dextrans are used therapeutically as plasma volume expanders and anticoagulants. They are also commonly used in biological experimentation and in industry for a wide variety of purposes. Dextran,Dextran 40,Dextran 40000,Dextran 70,Dextran 75,Dextran 80,Dextran B-1355,Dextran B-1355-S,Dextran B1355,Dextran B512,Dextran Derivatives,Dextran M 70,Dextran T 70,Dextran T-40,Dextran T-500,Hemodex,Hyskon,Infukoll,Macrodex,Polyglucin,Promit,Rheodextran,Rheoisodex,Rheomacrodex,Rheopolyglucin,Rondex,Saviosol,Dextran B 1355,Dextran B 1355 S,Dextran T 40,Dextran T 500
D005260 Female Females

Related Publications

L Prayer, and R Stiglbauer, and J Kramer, and D Wimberger, and D Poelzleitner, and W Schima, and C Kainz, and H Koelbl, and I Haugen, and H Imhof
Superparamagnetic particles as an oral contrast medium in abdominal magnetic resonance imaging.
January 1992, Acta radiologica. Supplementum,
L Prayer, and R Stiglbauer, and J Kramer, and D Wimberger, and D Poelzleitner, and W Schima, and C Kainz, and H Koelbl, and I Haugen, and H Imhof
Superparamagnetic particles as an oral contrast agent in abdominal magnetic resonance imaging.
November 1991, Investigative radiology,
L Prayer, and R Stiglbauer, and J Kramer, and D Wimberger, and D Poelzleitner, and W Schima, and C Kainz, and H Koelbl, and I Haugen, and H Imhof
Effect of superparamagnetic particles as oral contrast medium at magnetic resonance imaging. A phase I clinical study.
January 1989, Acta radiologica (Stockholm, Sweden : 1987),
L Prayer, and R Stiglbauer, and J Kramer, and D Wimberger, and D Poelzleitner, and W Schima, and C Kainz, and H Koelbl, and I Haugen, and H Imhof
Oral magnetic particles (ferristene) as a contrast medium in abdominal magnetic resonance imaging.
July 1996, Academic radiology,
L Prayer, and R Stiglbauer, and J Kramer, and D Wimberger, and D Poelzleitner, and W Schima, and C Kainz, and H Koelbl, and I Haugen, and H Imhof
Superparamagnetic particles as oral contrast medium in MR imaging of malignant lymphoma.
May 1991, Acta radiologica (Stockholm, Sweden : 1987),
L Prayer, and R Stiglbauer, and J Kramer, and D Wimberger, and D Poelzleitner, and W Schima, and C Kainz, and H Koelbl, and I Haugen, and H Imhof
Oral superparamagnetic particles for magnetic resonance imaging. Effect in plain and viscous aqueous suspensions.
May 1990, Acta radiologica (Stockholm, Sweden : 1987),
L Prayer, and R Stiglbauer, and J Kramer, and D Wimberger, and D Poelzleitner, and W Schima, and C Kainz, and H Koelbl, and I Haugen, and H Imhof
Superparamagnetic particles as gastrointestinal contrast agent in magnetic resonance imaging of lower abdomen.
July 1990, Acta radiologica (Stockholm, Sweden : 1987),
L Prayer, and R Stiglbauer, and J Kramer, and D Wimberger, and D Poelzleitner, and W Schima, and C Kainz, and H Koelbl, and I Haugen, and H Imhof
Monomer-coated very small superparamagnetic iron oxide particles as contrast medium for magnetic resonance imaging: preclinical in vivo characterization.
April 2002, Investigative radiology,
L Prayer, and R Stiglbauer, and J Kramer, and D Wimberger, and D Poelzleitner, and W Schima, and C Kainz, and H Koelbl, and I Haugen, and H Imhof
Magnetic resonance relaxation induced by superparamagnetic particles used as contrast agents in magnetic resonance imaging: a theoretical review.
November 2017, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology,
L Prayer, and R Stiglbauer, and J Kramer, and D Wimberger, and D Poelzleitner, and W Schima, and C Kainz, and H Koelbl, and I Haugen, and H Imhof
Superparamagnetic iron oxide (SPIO) as an oral contrast agent in gastrointestinal (GI) magnetic resonance imaging (MRI): comparison with state-of-the-art computed tomography (CT).
January 1996, Magnetic resonance imaging,
Copied contents to your clipboard!